This paper is in the following e-collection/theme issue:

Medicine 2.0: Social Media, Open, Participatory, Collaborative Medicine (1641) New Methods (944) Innovations and Technology in Cancer Care (423)

Published on in Vol 22, No 9 (2020): September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/19694, first published .
Exploring the Health-Related Quality of Life of Patients Treated With Immune Checkpoint Inhibitors: Social Media Study

Exploring the Health-Related Quality of Life of Patients Treated With Immune Checkpoint Inhibitors: Social Media Study

Exploring the Health-Related Quality of Life of Patients Treated With Immune Checkpoint Inhibitors: Social Media Study

Authors of this article:

François-Emery Cotté1 Author Orcid Image ;   Paméla Voillot2 Author Orcid Image ;   Bryan Bennett3 Author Orcid Image ;   Bruno Falissard4, 5, 6, 7 Author Orcid Image ;   Christophe Tzourio8, 9 Author Orcid Image ;   Pierre Foulquié2 Author Orcid Image ;   Anne-Françoise Gaudin1 Author Orcid Image ;   Hervé Lemasson1 Author Orcid Image ;   Valentine Grumberg10 Author Orcid Image ;   Laura McDonald11 Author Orcid Image ;   Carole Faviez2 Author Orcid Image ;   Stéphane Schück2 Author Orcid Image
Article Authors Cited by (12) Tweetations (23) Metrics

Journals

  1. Westeel V, Bourdon M, Cortot A, Debieuvre D, Toffart A, Acquadro M, Arnould B, Lambert J, Cotte F, Gaudin A, Lemasson H. Management of lung cancer patients' quality of life in clinical practice: a Delphi study. ESMO Open 2021;6(4):100239 View
  2. Renner S, Marty T, Khadhar M, Foulquié P, Voillot P, Mebarki A, Montagni I, Texier N, Schück S. A New Method to Extract Health-Related Quality of Life Data From Social Media Testimonies: Algorithm Development and Validation. Journal of Medical Internet Research 2022;24(1):e31528 View
  3. Wilczynski O, Boisbouvier A, Radoszycki L, Cotté F, Gaudin A, Lemasson H. Integrating Quality of Life in the Care Pathway of Cancer Patients Undergoing Immunotherapy Treatment: Descriptive, Cross-sectional Survey of an Online Patient Community's Experiences and Expectations. Journal of Medical Internet Research 2022;24(1):e25792 View
  4. Kalf R, Delnoij D, Ryll B, Bouvy M, Goettsch W. Information Patients With Melanoma Spontaneously Report About Health-Related Quality of Life on Web-Based Forums: Case Study. Journal of Medical Internet Research 2021;23(12):e27497 View
  5. Renner S, Loussikian P, Foulquié P, Marrel A, Barbier V, Mebarki A, Schück S, Bharmal M. Patient and Caregiver Perceptions of Advanced Bladder Cancer Systemic Treatments: Infodemiology Study Based on Social Media Data. JMIR Cancer 2023;9:e45011 View
  6. Grumberg V, Chouaïd C, Gaudin A, Le Tourneau C, Marabelle A, Bongiovanni-Delarozière I, Cotté F, Borget I. Organizational Impact of Immunotherapies in Advanced Cancers in France. JCO Global Oncology 2023;(9) View
  7. Meadows K, Reaney M. Story completion (SC) – an epistemological approach to the interpretation of patient-reported outcomes?. Expert Review of Pharmacoeconomics & Outcomes Research 2024;24(1):49 View
  8. Wang H, Dong Y, Fan T, Zhu S, Zhou Y, Song Y, Pan S, Wu Q, Li Y, Han Y. Health-related quality of life and its influencing factors among lung cancer patients receiving immune checkpoint inhibitors: A cross-sectional study. European Journal of Oncology Nursing 2024;68:102507 View
  9. Cimiano P, Collins B, De Vuono M, Escudier T, Gottowik J, Hartung M, Leddin M, Neupane B, Rodriguez-Esteban R, Schmidt A, Starke-Knäusel C, Voorhaar M, Wieckowski K. Patient listening on social media for patient-focused drug development: a synthesis of considerations from patients, industry and regulators. Frontiers in Medicine 2024;11 View
  10. Alwhaibi A, Alenazi M, Alnofaie S, Aldekhail A, Alanazi R, Alghadeer S, Alghamdi A, Alanazi S. Real-World Comparison of Health-Related Quality of Life Associated with Use of Immune-Checkpoint Inhibitors in Oncology Patients. Journal of Clinical Medicine 2024;13(16):4918 View
  11. Fan T, Zhu S, Wang H, Dong Y, Zhou Y, Song Y, Pan S, Wu Q, Smith G, Li Y, Han Y. Development and validation of the self-report symptom inventory of immune-related adverse events in patients with lung cancer. Asia-Pacific Journal of Oncology Nursing 2024;11(12):100603 View
  12. Grote C, Bohne A, Blome C, Kähler K. Quality of life under treatment with the immune checkpoint inhibitors ipilimumab and nivolumab in melanoma patients. Real-world data from a prospective observational study at the Skin Cancer Center Kiel. Journal of Cancer Research and Clinical Oncology 2024;150(10) View